149 related articles for article (PubMed ID: 28123191)
1. Characterization of Venous Thromboembolism Risk in Medical Inpatients Using Different Clinical Risk Assessment Models.
Rafizadeh R; Turgeon RD; Batterink J; Su V; Lau A
Can J Hosp Pharm; 2016; 69(6):454-459. PubMed ID: 28123191
[TBL] [Abstract][Full Text] [Related]
2. Concordance among venous thromboembolism risk assessment models.
Smilg Nicolás C; Tornel Sánchez G; Trujillo Santos J
Med Clin (Barc); 2018 Jan; 150(2):61-63. PubMed ID: 28743401
[TBL] [Abstract][Full Text] [Related]
3. Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE).
Nendaz M; Spirk D; Kucher N; Aujesky D; Hayoz D; Beer JH; Husmann M; Frauchiger B; Korte W; Wuillemin WA; Jäger K; Righini M; Bounameaux H
Thromb Haemost; 2014 Mar; 111(3):531-8. PubMed ID: 24226257
[TBL] [Abstract][Full Text] [Related]
4. Incidence of thromboembolism and thromboprophylaxis in medical patients admitted to specialized hospital in Ethiopia using Padua prediction score.
Asmamaw M; Hungnaw W; Motbainor A; Kedir HM; Tadesse TA
SAGE Open Med; 2022; 10():20503121221079488. PubMed ID: 35223033
[TBL] [Abstract][Full Text] [Related]
5. Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review.
Stuck AK; Spirk D; Schaudt J; Kucher N
Thromb Haemost; 2017 Apr; 117(4):801-808. PubMed ID: 28150851
[TBL] [Abstract][Full Text] [Related]
6. Validation of Risk Assessment Models Predicting Venous Thromboembolism in Inpatients with Acute Exacerbation Of Chronic Obstructive Pulmonary Disease: A Multicenter Cohort Study in China.
Zhou C; Yi Q; Ge H; Wei H; Liu H; Zhang J; Luo Y; Pan P; Zhang J; Peng L; Aili A; Liu Y; Wang M; Tang Y; Wang L; Zhong X; Wang Y; Zhou H;
Thromb Haemost; 2022 Jul; 122(7):1177-1185. PubMed ID: 34758489
[TBL] [Abstract][Full Text] [Related]
7. Underuse of medical thromboprophylaxis in mobile elderly inpatients: The SWITCO65+ cohort.
Blondon M; Limacher A; Righini M; Aujesky D; Méan M
Res Pract Thromb Haemost; 2021 Jan; 5(1):142-147. PubMed ID: 33537538
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the Risk of Venous Thromboembolism in Medical Inpatients using the Padua Prediction Score and Caprini Risk Assessment Model.
Zhou H; Hu Y; Li X; Wang L; Wang M; Xiao J; Yi Q
J Atheroscler Thromb; 2018 Nov; 25(11):1091-1104. PubMed ID: 29540637
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
[TBL] [Abstract][Full Text] [Related]
10. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study.
Davis S; Goodacre S; Horner D; Pandor A; Holland M; de Wit K; Hunt BJ; Griffin XL
BMJ Med; 2024; 3(1):e000408. PubMed ID: 38389721
[TBL] [Abstract][Full Text] [Related]
12. New paradigms in venous thromboprophylaxis of medically ill patients.
Spyropoulos AC; Raskob GE
Thromb Haemost; 2017 Aug; 117(9):1662-1670. PubMed ID: 28640324
[TBL] [Abstract][Full Text] [Related]
13. External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system.
Rosenberg D; Eichorn A; Alarcon M; McCullagh L; McGinn T; Spyropoulos AC
J Am Heart Assoc; 2014 Nov; 3(6):e001152. PubMed ID: 25404191
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the PADUA and IMPROVE scores in assessing venous thromboembolism risk in 42,257 medical inpatients in China.
Yifang H; Jun D; Jingting Y; Ying S; Ping Z; Xiaomei D
J Thromb Thrombolysis; 2024 Apr; ():. PubMed ID: 38643438
[TBL] [Abstract][Full Text] [Related]
15. Appropriateness of Pharmacologic Thromboprophylaxis Prescribing Based on Padua Score Among Inpatient Veterans.
Creith B; Givens G; Ragheb B; Naik N; Owen C; Wallace J
Fed Pract; 2022 Jul; 39(7):299-303a. PubMed ID: 36425351
[TBL] [Abstract][Full Text] [Related]
16. Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients.
Woller SC; Stevens SM; Jones JP; Lloyd JF; Evans RS; Aston VT; Elliott CG
Am J Med; 2011 Oct; 124(10):947-954.e2. PubMed ID: 21962315
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism prevention in medical patients: a framework for improving practice.
Vaughan-Shaw PG; Cannon C
Phlebology; 2011 Mar; 26(2):62-8. PubMed ID: 21228357
[TBL] [Abstract][Full Text] [Related]
18. External Validation of the Padua and IMPROVE-VTE Risk Assessment Models for Predicting Venous Thromboembolism in Hospitalized Adult Medical Patients: A Retrospective Single-Center Study in Japan.
Arakaki D; Iwata M; Terasawa T
Ann Vasc Dis; 2023 Mar; 16(1):60-68. PubMed ID: 37006863
[No Abstract] [Full Text] [Related]
19. The comparison between Caprini and Padua VTE risk assessment models for hospitalised cancer patients undergoing chemotherapy at the tertiary oncology department in Poland: is pharmacological thromboprophylaxis overused?
Łukaszuk RF; Dolna-Michno J; Plens K; Czyżewicz G; Undas A
Contemp Oncol (Pozn); 2018; 22(1):31-36. PubMed ID: 29692661
[TBL] [Abstract][Full Text] [Related]
20. Updated clinical models for VTE prediction in hospitalized medical patients.
Gerotziafas GT; Papageorgiou L; Salta S; Nikolopoulou K; Elalamy I
Thromb Res; 2018 Apr; 164 Suppl 1():S62-S69. PubMed ID: 29703486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
